Get access to our best features

Get access to our best features

Pfizer inks $43 billion Seagen deal to boost cancer portfolio

Summary by RTÉ
Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatment portfolio, as the drugmaker braces for a steep fall in COVID-19 product sales and loss of exclusivity for some top sellers.
Published 3 months ago · New York, United States

News Articles

More
Filters
All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

48% of the sources are Center
Associated Press News
abc News
The Washington Post
CBS News
Bloomberg
Alaska Highway News
+22
Reuters
CNBC
KRDO
KIFI
The Hill
RTÉ
+37
Times of India
News18 India
Washington Times
The News
National Post
Gulf News
+10
OAN
Le Journal de Montreal
The Daily Telegraph
L 29%
C 50%
R 21%
See less detail